Pacific Edge Limited Announces Proposed Issue of 200 Million Securities

An update from Pacific Edge Limited ( (PFGTF) ) is now available.

Pacific Edge Limited announced a proposed issue of up to 200 million securities, with 50 million offered under a securities purchase plan and 150 million through a placement. This move is part of the company’s strategy to raise capital, potentially enhancing its market position and operational capabilities in the biotechnology sector.

More about Pacific Edge Limited

Pacific Edge Limited operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests for the early detection and management of cancer. The company primarily offers non-invasive diagnostic tests for bladder cancer, aiming to improve patient outcomes and reduce healthcare costs.

Find detailed analytics on PFGTF stock on TipRanks’ Stock Analysis page.